Perotin, Jeanne-Marie
Gierski, Fabien
Bolko, Lois
Dury, Sandra
Barrière, Sarah
Launois, Claire
Dewolf, Maxime
Chouabe, Stéphane
Bongrain, Eric
Picard, Davy
Tran, Eric
N’Guyen, Yoann
Mourvillier, Bruno
Servettaz, Amélie
Rapin, Amandine
Marcus, Claude
Lebargy, François
Kaladjian, Arthur
Salmon, Jean-Hugues
Deslee, Gaetan
Clinical trials referenced in this document:
Documents that mention this clinical trial
Cluster analysis unveils a severe persistent respiratory impairment phenotype 3-months after severe COVID-19
https://doi.org/10.1186/s12931-022-02111-9
Funding for this research was provided by:
University Hospital of Reims, France (AOL 2020-COVID-19)
Article History
Received: 28 February 2022
Accepted: 9 July 2022
First Online: 2 August 2022
Declarations
:
: This study was approved by the French ethics committee (Comité de Protection des Personnes du Nord-Ouest IV, number 2020-A01260-39, 30 April 2020; NCT04376840). Written informed consent was obtained for each patient. All methods have been performed in accordance with the Declaration of Helsinki.
: Not applicable.
: The authors declare that they have no competing interests.